- $2.46bn
- $6.77bn
- $9.83bn
- 56
- 88
- 22
- 56
Annual income statement for Concentrix, fiscal year end - November 30th, USD millions except per share, conversion factor applied.
2021 November 30th | 2022 November 30th | 2023 November 30th | 2024 November 30th | 2025 November 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5,587 | 6,324 | 7,115 | 9,619 | 9,826 |
| Cost of Revenue | |||||
| Gross Profit | 1,969 | 2,257 | 2,578 | 3,449 | 3,435 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 5,015 | 5,684 | 6,509 | 9,023 | 10,744 |
| Operating Profit | 572 | 640 | 605 | 596 | -918 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 556 | 605 | 408 | 299 | -1,182 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 406 | 436 | 314 | 251 | -1,279 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 406 | 435 | 314 | 251 | -1,279 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 400 | 428 | 308 | 242 | -1,283 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 7.99 | 8.75 | 7.51 | 6.31 | -3.54 |
| Dividends per Share |